A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
Not Applicable
Completed
- Conditions
- Apnea of Prematurity
- Interventions
- Device: NCPAP as mode for apnea preventionDevice: NIPPV as rescue mode for apnea prevention
- Registration Number
- NCT03298035
- Brief Summary
The purpose of this study is to determine whether nasal intermittent positive pressure ventilation (NIPPV) reduces the need for endotracheal intubation in very low birth weight infants with persistent apnea who fail nasal continuous positive airway pressure (NCPAP).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
- Infants born at < 30 weeks gestational age who develop clinically significant apnea while on NCPAP > 6cm H2O or whose team is considering intubation due to apnea. Consider clinically significant apnea as 1 or more events treated with bag-mask ventilation or 3 episodes of apnea requiring stimulation within 1 hour.
- Infants on maximum caffeine therapy (10mg/kg/day)
Exclusion Criteria
- Major congenital anomalies including congenital heart disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description NCPAP as mode for apnea prevention NCPAP as mode for apnea prevention With recurrence of apneic events, infants on NCPAP will have changes made in NCPAP settings per the clinical team's discretion in attempt to prevent future apneic events. If apneic events persist despite NCPAP adjustments, clinicians may intubate based on clinical judgment. NIPPV as rescue mode for apnea prevention NIPPV as rescue mode for apnea prevention With recurrence of apneic events, infants will be placed on NIPPV with settings and adjustments per the clinical team's discretion. If apneic events persist despite NIPPV placement and setting adjustments, clinicians may intubate based on clinical judgment.
- Primary Outcome Measures
Name Time Method Number of Participants Who Were Intubated 28 days after randomization Duration of Intubation 28 days after randomization
- Secondary Outcome Measures
Name Time Method Number of Participants With Air Leak Disorders 36 weeks corrected gestational age Air leak disorders include pneumothorax and/or pneumomediastinum.
Weight Gain 36 weeks corrected gestational age Number of Apneic Events 28 days after randomization Number of Participants With Bronchopulmonary Dysplasia (BPD) 36 weeks corrected gestational age Length of Hospital Stay about 10 to 18 weeks Number of Participants Who Died until discharge (about 10 to 18 weeks) or death Number of Participants With Necrotizing Enterocolitis (NEC) 36 weeks corrected gestational age
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States